International Trade Today is providing readers with the top stories from last week in case they were missed. All articles can be found by searching on the titles or by clicking on the hyperlinked reference number.
With a short window for passing customs modernization legislation this year and uncertain prospects after that, it’s important that CBP and the trade community “stick the landing” of the 21st Century Customs Framework initiative and present a united front to Congress when a legislative proposal is submitted by CBP later this year, said John Drake, vice president-supply chain policy at the U.S. Chamber of Commerce.
FDA has issued its Enforcement Report for April 12, listing the status of recalls and field corrections for food, cosmetics, tobacco products, drugs, biologics and devices. The report covers both domestic and foreign firms.
Despite the success of its Section 321 data pilot, which has taught CBP lessons on the types of data on de minimis shipments it may find helpful and reduced hiccups for industry participants providing the additional data, CBP still has “quite a bit we can learn,” CBP’s Christopher Mabelitini said during a webinar April 12. In addition to expanding the number of participants covered by the pilot, CBP is looking to increase the universe of data and transactions.
International Trade Today is providing readers with the top stories from last week in case they were missed. All articles can be found by searching on the titles or by clicking on the hyperlinked reference number.
CBP released a new “slick sheet” April 10 with guidance for customs brokers on what to do when faced with cybersecurity incidents. “The new resource makes recommendations on how to prevent, respond to, and recover from potential cyber-attacks on customs broker data systems, from proactively putting in place plans and preventative IT controls to resuming normal business operations upon system remediation,” CBP said in a news release.
FDA has issued its Enforcement Report for April 5, listing the status of recalls and field corrections for food, cosmetics, tobacco products, drugs, biologics and devices. The report covers both domestic and foreign firms.
Hypodermic needle assemblies made in the U.S. by Cardinal Health from imported stainless steel needles and U.S.-made plastic parts keep the country of origin of the imported needles, CBP said in a recent ruling.
International Trade Today is providing readers with the top stories from last week in case they were missed. All articles can be found by searching on the titles or by clicking on the hyperlinked reference number.
A proposed formula for apportioning the value of tooling assists to imported auto parts can’t be used by an importer because it doesn’t take into consideration the country of origin of the imported parts and so fails to account for the possibility that they could be subject to additional Section 301 and Section 232 duties, CBP said in a ruling released March 27.